Production (Stage)
D
Beyond Medical Technologies Inc. DOCT
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 52.69% -107.85% -11.28% 1.27% 33.02%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -1,000.00% 104.86% 100.42% 102.93% 108.96%
Change in Net Operating Assets 532.89% 106.45% 502.55% 114.67% -41.46%
Cash from Operations 79.53% 83.94% 71.99% 58.74% 46.44%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 0.00% -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 0.90% -14.45% 44.63% 224.09% 862.07%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments 14.44% -54.20% -54.20% -54.20% -54.20%
Net Change in Cash 89.42% 94.72% 79.92% 65.99% 49.41%